TrialNutrients2017

Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.

Martin H de Borst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.